Recurrent ependymoma treated with high-dose tamoxifen in a peripubertal female: Impact on tumor and the pituitary-ovarian axis

Pediatric Blood and Cancer

Volumn 49, Issue 5, 2007, Pages 758-760

  Yoffe, Rona ^a   Khakoo, Yasmin ^b   Dunkel, Ira J ^b   Souweidane, Mark ^b   Lis, Eric ^b   Sklar, Charles ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Brain tumor; GnRH agonist; Ovarian cysts

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DEPOT LUPRON; ESTRADIOL; ETOPOSIDE; FOLLITROPIN; GONADORELIN; GONADORELIN AGONIST; LEUPRORELIN; LUTEINIZING HORMONE; TAMOXIFEN; UNCLASSIFIED DRUG; VINCRISTINE;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CASE REPORT; CLINICAL FEATURE; DRUG MEGADOSE; DRUG WITHDRAWAL; ECHOGRAPHY; EPENDYMOMA; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLOW UP; GONADORELIN TEST; HORMONE DETERMINATION; HUMAN; HYPOPHYSIS GONAD SYSTEM; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY CYST; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; SCHOOL CHILD; SEXUAL MATURATION; SIDE EFFECT; BLOOD; CHEMICALLY INDUCED DISORDER; CHILD; DRUG EFFECT; PUBERTY; TUMOR VOLUME;

CHILD; EPENDYMOMA; ESTRADIOL; FEMALE; HUMANS; OVARIAN CYSTS; PUBERTY; RECURRENCE; TAMOXIFEN; TUMOR BURDEN;

EID: 35148830718     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20647     Document Type: Article

References (16)

1. Ben Arush MW, Postovsky S, Goldsher D, et al. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatr Hematol Oncol 1999;16:245-250.
2. Madden JE, Fenton LZ, Weil M, et al. Experience with tamoxifen/etoposide in the treatment of a child with myxopapillary ependymoma. Med Pediatr Oncol 2001;37:67-69.
3. Merchant TE, Mulhern RK, Krasin MJ, et al. Preliminary results from a phase II trial of conformal radiation therapy and evaluation of radiation-related CNS effects for pediatric patients with localized ependymoma. J Clin Oncol 2004;22:3156-3162.
4. Couldwell WT, Weiss MH, DeGiorgio CM, et al. Clinical and radiographic response in a minority of patients with recurrent malignant gliomas treated with high-dose tamoxifen. Neurosurgery 1993;32:485-490.
5. Carmichael PL. Mechanism of action of antiestrogens: Relevance to clinical benefits and risks. Cancer Invest 1998;16:604-611.
6. Grainger DJ, Metcalfe JC. Tamoxifen: Teaching an old drug new tricks? Nat Med 1996;2:381-385.
7. Baltuch GH, Couldwell WT, Villeneneuve JG, et al. Protein kinase C inhibitors suppress cell growth in established and low passage glioma cell lines: A comparison between staurosporine and tamoxifen. Neurosurgery 1993;33:495-501.
8. Pollack IF, Randall MS, Kristofik MP, et al. Effect of tamoxifen on DNA synthesis and proliferation of human malignant glioma lines in vitro. Cancer Res 1990;50:7134-7138.
9. Ramachandran C, Khative Z, Pefkarou A, et al. Tamoxifen modulation of etoposide cytotoxicity involves inhibition of protein kinase C activity and insulin-like growth factor II expression in brain tumor cells. J Neuro-Oncol 2004;67:19-28.
10. Pollack IF, DaRosso RC, Robertson PL, et al. A phase 1 study of high-dose tamoxifen for the treatment of refractory malignant gliomas of childhood. Clin Cancer Res 1997;3:1109-1115.
11. Walter AW, Gajjar A, Reardon DA, et al. Tamoxifen and carboplatin for children with low grade gliomas: A pilot study at St. Jude Childrens Research Hospital. J Pediatr Hematol Oncol 2000;22:247-251.
12. Riggs BL, Hartmann LC. Selective estrogen-receptor modulators - Mechanism of action and application to clinical practice. New Engl J Med 2003;348:618-629.
13. Seod M, El-saghir N, Salem Z, et al. Tamoxifen and ovarian cysts: A prospective study. Eur J Obstet Gynecol Reprod Biol 2001;100:77-80.
14. Groom GV, Griffiths K. The effect of the anti-oestrogen tamoxifen on plasma levels of luteinizing hormone, follicle-stimulating hormone, prolactin, oestradiol and progesterone in normal premenopausal women. J Endocrinol 1976;70:421-428.
15. Ravdin PM, Fritz NF, Tormey DC, et al. Endocrine status of premenopausal node-positive breast cancer patients following adjuvant chemotherapy and long-term tamoxifen. Cancer Res 1988;48:1026-1029.
16. Shulman A, Cohen I, Altaras MM, et al. Ovarian cyst formation in two pre-menopausal patients treated with tamoxifen for breast cancer. Hum Reprod 1994;9:1427-1429.